The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

The rollout of antiretroviral therapy for HIV showed how global solidarity and smart policy can overcome barriers to new treatments, say Jirair Ratevosian and Jeffrey L Sturchio The arrival of ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

An organization that bills itself as Canada’s oldest HIV service agency will close next year, in part due to groundbreaking ...

Despite marked progress in the HIV response in 2024, this year has seen many disruptions to HIV prevention programmes and ...

The Global Fund also indicates that awareness of HIV status is nearly universal. In 2015, 87 percent of people living with ...

Despite medical advancements, HIV remains a serious public health issue in the United States, with about 30,000 new diagnoses reported each year, according to federal data. Dr. Andrew See, a ...

A man living with advanced HIV carried COVID-19 for more than 750 days. During the chronic infection, the virus mutated ...

A single dose of benzathine benzylpenicillin G is as effective as three doses for early syphilis, including in people with ...